Georgia Milaki - Concepedia

Author

Georgia Milaki

University Hospital of Heraklion

Also Known As

G Milaki, G. Milaki, Georgia Milaki

Publications

419

Citations

H-Index

Concepts

All Affiliations

University Hospital of Heraklion National and Kapodistrian University of Athens Theageneio General Hospital University of Crete Sismanoglio General Hospital

About

Georgia Milaki is an author at University Hospital of Heraklion specializing in cancer therapeutics, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	76
2	Health Sciences	2	2	25
3	Geriatrics	1	1	10
4	Obstetrics	1	1	15
5	Pathology	1	1	14

Georgia Milaki

Publications

389

Citations

H-Index

Page 1

	Year	Citations
SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer Ioanna Balgkouranidou, Maria Chimonidou, Georgia Milaki, Clinical Chemistry and Laboratory Medicine (CCLM)	2016	92
Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer Ioanna Balgkouranidou, Maria Chimonidou, Georgia Milaki, British Journal of Cancer	2014	81
Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II Trial John Souglakos, Athanasios Pallis, Stylianos Kakolyris, Oncology	2005	62
Front-Line Chemotherapy with Docetaxel and Gemcitabine Administered Every Two Weeks in Patients with Metastatic Breast Cancer: A Multicenter Phase II Study D. Mavroudis, Nikolaos Malamos, Aris Polyzos, Oncology	2004	27
Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer. Emmanouil Saloustros, K. Kalbakis, N. Vardakis, PubMed	2011	20
Treatment of relapsed urothelial bladder cancer with vinflunine Nikolaos Pistamaltzian, Kimon Tzannis, Vassiliki Pissanidou, Anti-Cancer Drugs UrologyGenitourinary CancerUrothelial CancerMedicineCancer Management	2015	19
A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer Sofia Agelaki, M. Veslemes, Kostas Syrigos, Lung Cancer OncologyMedicineBronchial NeoplasmPharmacotherapyCancer Treatment	2003	18
A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer Sofia Agelaki, K. Syrigos, Charalambos Christophylakis, Oncology	2004	16
A Multicenter Phase II Trial with Irinotecan plus Oxaliplatin as First-Line Treatment for Inoperable/Metastatic Cancer of the Biliary Tract Niki Karachaliou, Aris Polyzos, Nikolaos Kentepozidis, Oncology	2010	15
A phase I-II trial of gefitinib in combination with vinorelbine and oxaliplatin as salvage therapy in women with advanced ovarian cancer (AOC) D. Mavroudis, Eleni Efstathiou, A. Polyzos, Journal of Clinical Oncology Cancer ManagementGynecologyPharmacotherapyGynecology OncologyOvarian Cancer	2004	15

Page 1